Disposition of 634 shares by Ginger Gregory of Biogen at 240.98 subject to Rule 16b-3
IDP Stock | 149.50 5.80 4.04% |
Slightly above 55% of Biogen's private investors are presently thinking to get in. The analysis of current outlook of investing in Biogen Inc suggests that some traders are interested regarding Biogen's prospects. Biogen's investing sentiment can be driven by a variety of factors including economic data, Biogen's earnings reports, geopolitical events, and overall market trends.
Biogen |
Filed transaction by Biogen Inc Officer Evp, Human Resources. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Biogen Fundamental Analysis
We analyze Biogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earnings To Growth
Price To Earnings To Growth Comparative Analysis
PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Peers
Trending Equities
Additional Tools for Biogen Stock Analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.